GSK
GSK signs Adaptimmune deal
June 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology
GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …
GSK pondering £7.5 billion drugs sale
May 30, 2014Sales and Marketing GSK, Paxil, ageing, drugs, established, imitrex, zofran
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
GSK now faces UK investigation
May 28, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Poland, UK, bribery, corruption, iraq, sfo
The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …
Authorities visit Roche China offices
May 23, 2014Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic
A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …
Heartbreak for Novartis as FDA rejects drug
May 18, 2014Research and Development, Sales and Marketing GSK, Novartis, heart drug
Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …
More late-stage anguish for GSK heart drug
May 14, 2014Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart
GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …
GSK China head arrested over bribery charges
May 14, 2014Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly
A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …
Wellcome Trust slams Pfizer/AstraZeneca bid
May 9, 2014Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover
The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …
GSK sees profit fall
May 1, 2014Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty
GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …
Pharma playing catch-up in mHealth race
April 30, 2014Medical Communications, Sales and Marketing GSK, Havas, butler, digital, gait, mhealth, mobile health, pm awards
Pharma risks falling behind in mobile health (mHealth) as more innovative industries capitalise on its emerging opportunities, according to two …
Mekinist shown green light by CHMP
April 28, 2014Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib
GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …
Valeant makes $45.7 billion Allergan offer
April 23, 2014Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing
In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …
GSK and Novartis sign multi-billion dollar deal
April 23, 2014Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines
GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …
GSK bribery controversy spreads to Poland
April 14, 2014Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq
Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
